Evidence map

ArticleObesity science & practice2019

Beinaglutide showed significant weight-loss benefit and effective glycaemic control for the treatment of type 2 diabetes in a real-world setting: a 3-month, multicentre, observational, retrospective, open-label study.

Y L Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

34 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31452921